483
Charles E. Canter, MDCharles E. Canter, MD – FDA 483, Dec 20, 2021
Record Details
An FDA inspection of Charles E. Canter, MD in St Louis, MO, a clinical investigator site, revealed significant deficiencies in the conduct of an investigational study. Observations included failures to confirm subject exclusion criteria, document investigator review of eligibility, and confirm end-of-study visits. Additionally, inadequate investigational drug disposition records and incomplete case histories were noted.
View Company Profile
ID · 3739e1ab-0947-4197-8742-1224c092b222
Other documents for Charles E. Canter, MD
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.